Results: CD3 + and CD8 + TILs were identified at both CT and IM and enriched at IM. High density of CD3 + TILs at IM (CD3 IM) was significantly associated with increased overall and disease-specific survival (P < .05). High density of CD8 + TILs at CT (CD8 CT) was significantly associated with increased overall but not diseasespecific survival. Moreover, CD3 IM and CD8 CT were identified as independent prognostic factors for patient survival. Novel prognostic parameters with adequate specificity and sensitivity are still urgently needed for optimized patient stratification, treatment selection and prognostic prediction in the clinic.
Conclusions
Deregulated immune function has been demonstrated to be intricately involved in tumor initiation and progression. In particular, diverse types of tumor-infiltrating lymphocytes (TILs) produced different effects on tumor growth, recurrence, and metastatic spreading. 6 Accumulating evidence has shown that the presence of TILs is significantly correlated with prognosis of various solid tumors, such as head neck squamous cell carcinoma (HNSCC), 7-9 gastric cancer, 10,11 colorectal cancer, 12,13 breast cancer, 14 and non-small cell lung cancer. 15 Currently, the most common markers for TILs are CD3 and CD8 which label pan-T and cytotoxic T cells, respectively.
Mounting evidence has established that various numbers and types of TILs have been identified in different locations, for example within tumor or surrounding the tumor. Indeed, they are not randomly distributed but are located in specific areas. 6, 16, 17 and CD8 was performed on paraffin sections of 4 lm thickness as described previously. 22 
| Evaluation of immunohistochemical variables
The Images of these selected areas were captured using an inverted research microscope (Leica DM4000B, Germany). OSCC. In the Wuxi cohort, the univariate analysis revealed that low CD3 IM, CD8 CT and advanced clinical stage were significantly associated with inferior OS (P = .005, P = .036, and P = .025, respectively; Table 3 ). Complementary, the Kaplan-Meier survival analyses showed that patients with higher CD3 IM and CD8 CT had better prognosis than those with lower CD3 + and CD8 + TIL staining (P = .0036 and P = .0284, respectively; Figure 3A ,G), whereas CD3
CT and CD8 IM had no significant effects on OS ( Figure 3C ,E).
Moreover, only CD3 IM was found to be positively associated with disease-specific survival (P = .0063; Figure 3B ). Furthermore, we included statistical significant variables in univariate analysis as well as variables with important clinical significance and then performed multivariate Cox proportional regression analyses. As shown in To date, several lines of evidence have revealed that high density of TILs associates with favorable prognosis in a broad spectrum of human solid cancers including head neck cancer, oral cancer as well as breast cancer. 7, 14, 21, 25 High CD3 + or CD8 + TILs was found to be an independent factor for favorable overall survival, local progression-free survival, and distant metastasis-free survival by examining samples from 161 head neck cancer with median follow-up of 48 months. 26 In addition, a recent retrospective study with 278 patients reported that increased CD4 + and CD8 + TIL levels were associated with improved overall survival and recurrence-free survival, and represented as significant independent prognostic factors for HNSCC. 7 However, the clinical significance and prognostic values of TILs in OSCC varied among previous studies. In conclusions, our data indicate that high densities of CD3 + and CD8 + TILs at tumor center and invasive margins significantly associate with improved overall survival in patients with primary OSCC.
Moreover, the abundance of CD3 + TILs at invasive margins and CD8 + TILs at tumor center is independent prognostic factor for OSCC. Together, our finding provides further evidence of the prognostic importance of the CD3 + and CD8 + TILs in OSCC, and also suggests that T-cell infiltrate subsets have antitumor effects against OSCC which could be exploited for therapeutic intervention.
